Feliza Mirasol

Automation promises to connect biomanufacturing processes more closely, and to bring greater efficiency to the manufacturing floor.

Current practices for cleaning and sterilizing biomanufacturing equipment does not differ much between a multi-product versus single-product setting.

Large biopharmas, emerging biotechs, and CMOs are looking for novel ways to improve the productivity of biologics in a rapidly evolving biotherapeutics market.

This article takes a look at current practices for cleaning and sterilizing biomanufacturing equipment used in a multi-product versus single-product setting.

Single-use technology is gaining ground in downstream bioprocessing, but challenges stall further adoption.

The market for biosimilars in Europe remains consistently robust, with 16 new biosimilars approved in 2018.

A look at some best practices to ensure that quality control is maintained in the client–vendor relationship.

The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality.

As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.

This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.

Modular manufacturing systems offer a less costly way to increase capacity while reducing time-to-market.

Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.

CMOs have been active over the past year in expanding their biologics production and capabilities.

Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.

Stability testing on APIs/finished drug product helps define optimal drug packaging for shelf-life storage.

Stability testing on APIs/finished drug product is crucial to ensuring proper packaging for optimum shelf-life storage.

Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.

Partnership dictates the success of outsourcing relationships in early phase drug-development analytics.

In a roundtable Q&A with biopharma executives, the vulnerability and challenges of dealing with extractables and leachables in single-use bioreactor bags are explored.

The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.